SecBot SecBot
PRESS-RELEASE ·Filed Aug 3, 2026

NATR

Nature's Sunshine Products, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed2mo ago WireGlobeNewswire
Press release · Leadership
Actionable Insight • Neutral

Monitor Nature's Sunshine's next 10-Q for any commentary on North America revenue trends or strategic shifts under the new leadership. No immediate trading catalyst — the appointment is routine and lacks financial details to drive material stock movement.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
NATR ▼ -41.67% at T+60d
NEUTRAL call -41.67% · α vs SPY -43.45% · entry $21.14 → $12.33
Entry = T+0 close
Aug 3, 2026
via day close
T+1d
-3.22%
call -3.22% · α -5.02%
$20.46
settled 3mo ago
T+5d
-25.40%
call -25.40% · α -27.43%
$15.77
settled 3mo ago
T+20d
-33.07%
call -33.07% · α -34.30%
$14.15
settled 8w ago
T+60d
-41.67%
call -41.67% · α -43.45%
$12.33
settled 10h ago

Price Chart

Loading chart...

Executive Summary

Nature's Sunshine appointed Janine Weber as EVP and President, North America, effective August 10, 2026. Weber brings over 25 years of direct-selling leadership from LifeWave and Rodan + Fields to lead the company's U.S. and Canada business. This is a routine senior executive hire with no accompanying financial disclosures or guidance changes.

Key Facts

  • Janine Weber appointed EVP and President, North America, effective August 10, 2026
  • Weber has 25+ years of direct-selling experience, most recently as Regional President, North America at LifeWave, and previously Senior Vice President roles at Rodan + Fields
  • Weber will oversee Nature's Sunshine's U.S. and Canada operations, focusing on growth, consultant engagement, and customer experience

Financial Impact

No financial figures disclosed — appointment has no immediate quantifiable impact

Risk Factors

  • Execution risk if new leadership fails to deliver growth in North America
  • Potential short-term disruption during leadership transition period

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3337818
12 reports for NATR
Performance horizon
50% Hit rate @ T+1 2 of 4 directional calls Went positive at some point 2 of 4 best @ T+20▲ +9.25%Mar 10, 2026
Filters
Rows
Reports for NATR — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G/A
NEUTRAL ★ 2/10
—awaiting T+1——
Oct 21, 2026
6d ago
Press Release
NEUTRAL ★ 1/10
$12.41awaiting T+1—$12.39 (−0.16%)
Aug 19, 2026
9w ago
Insider Buy
BULLISH ★ 5/10
$14.32 $14.34▲ +0.14%▼ −0.27%$12.39 (−13.48%)
Aug 10, 2026
11w ago
Insider Buy
BULLISH ★ 5/10
$15.99 $15.51▼ −3.00%▼ −3.25%$12.39 (−22.51%)
Aug 3, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$21.14 $20.46▼ −3.22%▼ −5.02%$12.39 (−41.39%)
Jun 15, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$20.08 $20.08· 0.00%▲ +1.25%$12.39 (−38.30%)
Jun 11, 2026
19w ago
Insider Cluster
NEUTRAL ★ 4/10
$20.51 $20.04▼ −2.29%▼ −4.05%$12.39 (−39.59%)
May 7, 2026
24w ago
8-K
BULLISH ★ 6/10
$24.23 $22.18▼ −8.46%▼ −8.69%$12.39 (−48.87%)
Apr 23, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$27.33 $27.43▲ +0.37%▲ +0.20%$12.39 (−54.67%)
Apr 20, 2026
27w ago
DEFA14A
NEUTRAL ★ 3/10
$26.41 $26.91▲ +1.89%▲ +0.87%$12.39 (−53.09%)
Showing 10 of 12

US Market Status

Market Closed — Opens Wed (15h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 3, 2026